Table 1.
Case No. | Adverse Event |
---|---|
Theracurmin group | |
6 | Brain bleeding |
Placebo group | |
8 | Fracture and Infection |
27 | Cholecystitis and Dermatitis |
35 | Infection and Dermatitis |
Case No. | Adverse Event |
---|---|
Theracurmin group | |
6 | Brain bleeding |
Placebo group | |
8 | Fracture and Infection |
27 | Cholecystitis and Dermatitis |
35 | Infection and Dermatitis |